IDO1 and pancreatic neoplasm: Witkiewicz et al. assumed that the influence of a cytokine-rich milieu (including IFN-γ) in the lymph nodes enhances IDO expression in metastatic pancreatic cancer cells which have traveled to the lymph nodes [54].